↓ Skip to main content

Dove Medical Press

Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

Overview of attention for article published in Lung Cancer: Targets and Therapy, January 2017
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#36 of 128)
  • Good Attention Score compared to outputs of the same age (69th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
72 Mendeley
Title
Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives
Published in
Lung Cancer: Targets and Therapy, January 2017
DOI 10.2147/lctt.s105678
Pubmed ID
Authors

Ashwin Somasundaram, Timothy F Burns

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 15%
Student > Bachelor 11 15%
Student > Doctoral Student 8 11%
Student > Master 8 11%
Other 7 10%
Other 12 17%
Unknown 15 21%
Readers by discipline Count As %
Medicine and Dentistry 22 31%
Pharmacology, Toxicology and Pharmaceutical Science 8 11%
Biochemistry, Genetics and Molecular Biology 7 10%
Nursing and Health Professions 5 7%
Agricultural and Biological Sciences 4 6%
Other 5 7%
Unknown 21 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2022.
All research outputs
#7,355,930
of 25,374,647 outputs
Outputs from Lung Cancer: Targets and Therapy
#36
of 128 outputs
Outputs of similar age
#126,087
of 421,653 outputs
Outputs of similar age from Lung Cancer: Targets and Therapy
#1
of 1 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 128 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,653 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them